The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
African spitting cobras are unique among cobras for their potent anticoagulant venom activity arising from strong inhibition of Factor Xa. This anticoagulant effect is exerted by venom phospholipase A 2 (Group I PLA 2) toxins whose activity contributes to the lethality of these species. This anticoagulant toxicity is particularly problematic as it is not neutralized by current antivenoms. Previous work demonstrated this trait for Naja mossambica, N. nigricincta, N. nigricollis, and N. pallida. The present work builds upon previous research by testing across the full taxonomical range of African spitting cobras, demonstrating that N. ashei, N. katiensis, and N. nubiae are also potently anticoagulant through the inhibition of Factor Xa, and therefore the amplification of potent anticoagulant activity occurred at the base of the African spitting cobra radiation. Previous work demonstrated that the enzyme-inhibitor varespladib was able to neutralize this toxic action for N. mossambica, N. nigricincta, N. nigricollis, and N. pallida venoms. The current work demonstrates that varespladib was also able to neutralize N. ashei, N. katiensis, and N. nubiae. Thus varespladib is shown to have broad utility across the full range of African spitting cobras. In addition, we examined the cross-reactivity of the metalloprotease inhibitor prinomastat, which had been previously intriguingly indicated as being capable of neutralizing viperid venom PLA 2 (Group II PLA 2). In this study prinomastat inhibited the FXa-inhibiting PLA 2 toxins of all the African spitting cobras at the same concentration at which it has been shown to inhibit metalloproteases, and thus was comparably effective in its cross-reactivity. In addition we showed that the metalloprotease-inhibitor marimastat was also able to cross-neutralize PLA 2 but less effectively than prinomastat. Due to logistical (cold-chain requirement) and efficacy (cross-reactivity across snake species) limitations of traditional antivenoms, particularly in developing countries where snakebite is most common, these small molecule inhibitors (SMIs) might hold great promise as initial, field-based, treatments for snakebite envenoming as well as addressing fundamental limitations of antivenom in the clinical setting where certain toxin effects are unneutralized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings are also consistent with prior studies that have shown marimastat and another SVMP inhibitor, prinomastat, can reduce PLA2-based anticoagulant venom effects (54).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gutiérrez, J. M., Lewin, M. R., Williams, D. J., & Lomonte, B. (2020) · Toxins · doi:10.3390/toxins12020131 · Cited by 92
Self-citation
Research works printed but not linked: 52
- Kasturiratne, 2008, The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths, PloS Med, 5, 10.1371/journal.pmed.0050218 · DOI · Paper page
- Gutiérrez, 2017, Snakebite Envenoming, Nat Rev Dis Prim, 3, 17063, 10.1038/nrdp.2017.63 · DOI · Paper page
- Musah, 2019, Epidemiology, Ecology and Human Perceptions of Snakebites in a Savanna Community of Northern Ghana, PloS Negl Trop Dis, 13, 1, 10.1371/journal.pntd.0007221 · DOI
- Habib, 2013, Public Health Aspects of Snakebite Care in West Africa: Perspectives From Nigeria, J Venom Anim Toxins Incl Trop Dis, 19, 1, 10.1186/1678-9199-19-27 · doi:10.1186/1678-9199-19-27
- Williams, 2019, Strategy for a Globally Coordinated Response to a Priority Neglected Tropical Disease: Snakebite Envenoming, PloS Negl Trop Dis, 13, 1, 10.1371/journal.pntd.0007059 · DOI · Paper page
- Wüster, 2007, Get an Eyeful of This: A New Species of Giant Spitting Cobra From Eastern and North-Eastern Africa (Squamata: Serpentes: Elapidae, Naja) Zootaxa, 1532, 51, 10.11646/zootaxa.1532.1.4 · doi:10.11646/zootaxa.1532.1.4
- Shine, 2006, Ecology of Cobras From Southern Africa, J Zool, 272, 10.1111/j.1469-7998.2006.00252.x · doi:10.1111/j.1469-7998.2006.00252.x
- Wilkins, 2018, Snakebites in Africa and Europe: A Military Perspective and Update for Contemporary Operations, J R Army Med Corps, 164, 10.1136/jramc-2017-000883 · doi:10.1136/jramc-2017-000883
- Wüster, 2007, The Phylogeny of Cobras Inferred From Mitochondrial DNA Sequences: Evolution of Venom Spitting and the Phylogeography of the African Spitting Cobras (Serpentes: Elapidae, Naja Nigricollis Complex) Mol Phylogenet Evol, 45, 10.1016/j.ympev.2007.07.021 · DOI
- Westhoff, 2005, The Spitting Behavior of Two Species of Spitting Cobras, J Comp Physiol A Neuroethol Sensory Neural Behav Physiol, 191, 10.1007/s00359-005-0010-8 · DOI
- Kazandjian, 2021, Convergent Evolution of Pain-Inducing Defensive Venom Components in Spitting Cobras, Science (80-), 371, 10.1126/science.abb9303 · DOI · Paper page
- Panagides, 2017, How the Cobra Got Its Flesh-Eating Venom: Cytotoxicity as a Defensive Innovation and its Co-Evolution With Hooding, Aposematic Marking, and Spitting, Toxins (Basel), 9, 1, 10.3390/toxins9030103 · DOI
- Chu, 2010, Venom Ophthalmia Caused by Venoms of Spitting Elapid and Other Snakes: Report of Ten Cases With Review of Epidemiology, Clinical Features, Pathophysiology and Management, Toxicon, 56, 10.1016/j.toxicon.2010.02.023 · doi:10.1016/j.toxicon.2010.02.023
- Modler, 2012, Snake Bite in Southern Africa: Diagnosis and Management, C Your SA J CPD, 30
- Hoffman, 2015, Venom Ophthalmia From Naja Mossambica in Kwazulu Natal, South Africa: A Reminder to All That for Ocular Chemical Injury, Dilution Is the Solution, Trop Doct, 45, 10.1177/0049475514564695 · doi:10.1177/0049475514564695
- Saaiman, 2019, Spitting Cobra (Naja Nigricincta Nigricincta) Bites Complicated by Rhabdomyolysis, Possible Intravascular Haemolysis, and Coagulopathy, South Afr Med J, 109, 10.7196/SAMJ.2019.v109i10.14103 · doi:10.7196/samj.2019.v109i10.14103
- Simpson, 2009, The Anti Snake Venom Crisis in Africa: A Suggested Manufacturers Product Guide, Wilderness Environ Med, 20, 10.1580/08-WEME-CON-296R1.1 · doi:10.1580/08-weme-con-296r1.1
- Tilbury, 1982, Observations on the Bite of the Mozambique Spitting Cobra (Naja Mossambica Mossambica), S Afr Med J, 61, 10.10520/AJA20785135_14484 · doi:10.10520/aja20785135_14484
- Schiermeier, 2015, Africa Braced for Snakebite Crisis, Nature, 525, 299, 10.1038/525299a · DOI
- Kazandjian, 2021, Anticoagulant Activity of Naja Nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib, Toxins (Basel), 13, 302, 10.3390/toxins13050302 · DOI
- Hus, 2018, First Look at the Venom of Naja Ashei, Molecules, 23, 1, 10.3390/molecules23030609 · DOI
- Petras, 2011, Snake Venomics of African Spitting Cobras: Toxin Composition and Assessment of Congeneric Cross-Reactivity of the Pan-African Echitab-Plus-ICP Antivenom by Antivenomics and Neutralization Approaches, J Proteome Res, 10, 10.1021/pr101040f · DOI · Paper page
- Khalid, 2015, Cytotoxiciy of Naja Nubiae (Serpentes: Elapidae) and Echis Ocellatus (Serpentes: Viperidae) Venoms From Sudan, J Toxins, 2015, 1, 10.1155/2015/167492 · doi:10.1155/2015/167492
- Katali, 2020, Protein Identification of Venoms of the African Spitting Cobras, Naja Mossambica and Naja Nigricincta Nigricincta, Toxins (Basel), 12, 1, 10.3390/toxins12080520 · DOI
- Zhang, 2019, Naja Mossambica Mossambica Cobra Cardiotoxin Targets Mitochondria to Disrupt Mitochondrial Membrane Structure and Function, Toxins (Basel), 11, 152, 10.3390/toxins11030152 · DOI
- Bittenbinder, 2018, Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom But Are by LY315920 (Varespladib), Toxins (Basel), 10, 516, 10.3390/toxins10120516 · DOI · Paper page
- Kerns, 1999, Targeting of Venom Phospholipases: The Strongly Anticoagulant Phospholipase A2 From Naja Nigricollis Venom Binds to Coagulation Factor Xa to Inhibit the Prothrombinase Complex, Arch Biochem Biophys, 369, 10.1006/abbi.1999.1345 · DOI
- Salvador, 2019, Structural Basis for Phospholipase A2-Like Toxin Inhibition by the Synthetic Compound Varespladib (LY315920), Sci Rep, 9, 1, 10.1038/s41598-019-53755-5 · DOI · Paper page
- Stefansson, 1990, The Basic Phospholipase A2 From Naja Nigricollis Venom Inhibits the Prothrombinase Complex by a Novel Nonenzymatic Mechanism, Biochemistry, 29, 10.1021/bi00485a024 · DOI
- Chowdhury, 2021, Clinical Implications of Differential Procoagulant Toxicity of the Palearctic Viperid Genus Macrovipera, and the Relative Neutralization Efficacy of Antivenoms and Enzyme Inhibitors, Toxicol Lett, 340, 77, 10.1016/j.toxlet.2020.12.019 · DOI
- Piszkiewicz, 2013, Molecularly-Imprinted Nanoparticles That Recognize Naja Mossambica Cytotoxins: Binding Studies and Biological Effects, Chem Commun, 49, 10.1039/c3cc42394h · doi:10.1039/c3cc42394h
- Lewin, 2016, Varespladib (LY315920) Appears to be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation, Toxins (Basel), 8, 1, 10.3390/toxins8090248 · DOI · Paper page
- Zdenek, 2020, Anticoagulant Activity of Black Snake (Elapidae: Pseudechis) Venoms: Mechanisms, Potency, and Antivenom Efficacy, Toxicol Lett, 330, 10.1016/j.toxlet.2020.05.014 · DOI
- Youngman, 2020, Varespladib (LY315920) Neutralises Phospholipase a 2 Mediated Prothrombinase-Inhibition Induced by Bitis Snake Venoms, Comp Biochem Physiol Part C, 236, 10.1016/j.cbpc.2020.108818 · DOI
- Chowdhury, 2021, Venom-Induced Blood Disturbances by Palearctic Viperid Snakes, and Their Relative Neutralization by Antivenoms and Enzyme-Inhibitors, Front Immunol, 12, 10.3389/fimmu.2021.688802 · DOI
- Debono, 2019, Clinical Implications of Differential Antivenom Efficacy in Neutralising Coagulotoxicity Produced by Venoms From Species Within the Arboreal Viperid Snake Genus, Trimeresurus Toxicol Lett, 316, 35, 10.1016/j.toxlet.2019.09.003 · DOI
- Zdenek, 2019, Clinical Implications of Convergent Procoagulant Toxicity and Differential Antivenom Efficacy in Australian Elapid Snake Venoms, Toxicol Lett, 316, 10.1016/j.toxlet.2019.08.014 · DOI
- Zdenek, 2019, Coagulotoxic Effects by Brown Snake (Pseudonaja) and Taipan (Oxyuranus) Venoms, and the Efficacy of a New Antivenom, Toxicol Vitr, 58, 97, 10.1016/j.tiv.2019.03.031 · DOI
- Rogalski, 2017, Differential Procoagulant Effects of Saw-Scaled Viper (Serpentes: Viperidae: Echis) Snake Venoms on Human Plasma and the Narrow Taxonomic Ranges of Antivenom Efficacies, Toxicol Lett, 280, 10.1016/j.toxlet.2017.08.020 · DOI
- Lister, 2017, Catch a Tiger Snake by its Tail: Differential Toxicity, Co-Factor Dependence and Antivenom Efficacy in a Procoagulant Clade of Australian Venomous Snakes, Comp Biochem Physiol Part - C Toxicol Pharmacol, 202, 39, 10.1016/j.cbpc.2017.07.005 · DOI
- Dobson, 2018, Rattling the Border Wall: Pathophysiological Implications of Functional and Proteomic Venom Variation Between Mexican and US Subspecies of the Desert Rattlesnake Crotalus Scutulatus, Comp Biochem Physiol Part - C Toxicol Pharmacol, 205, 10.1016/j.cbpc.2017.10.008 · doi:10.1016/j.cbpc.2017.10.008
- Sunagar, 2014, Intraspecific Venom Variation in the Medically Significant Southern Pacific Rattlesnake (Crotalus Oreganus Helleri): Biodiscovery, Clinical and Evolutionary Implications, J Proteomics, 99, 68, 10.1016/j.jprot.2014.01.013 · DOI
- 2011, Varespladib, Am J Cardiovasc Drugs, 11, 10.2165/11533650-000000000-00000 · DOI · Paper page
- Albulescu, 2020, A Therapeutic Combination of Two Small Molecule Toxin Inhibitors Provides Broad Preclinical Efficacy Against Viper Snakebite, Nat Commun, 11, 1, 10.1038/s41467-020-19981-6 · DOI · Paper page
- Lewin, 2018, Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs From Lethal Doses of Micrurus Fulvius (Eastern Coral Snake) Venom, Toxins (Basel), 10, 1, 10.3390/toxins10110479 · DOI · Paper page
- Preciado, 2018, Low Molecular Mass Natural and Synthetic Inhibitors of Snake Venom Metalloproteinases, Toxin Rev, 37, 19, 10.1080/15569543.2017.1309550 · doi:10.1080/15569543.2017.1309550
- Vandenbroucke, 2014, Is There New Hope for Therapeutic Matrix Metalloproteinase Inhibition, Nat Rev Drug Discov, 13, 10.1038/nrd4390 · DOI · Paper page
- Kandiwa, 2018, Quantitative Characterization of the Hemorrhagic, Necrotic, Coagulation-Altering Properties and Edema-Forming Effects of Zebra Snake (Naja Nigricincta Nigricincta) Venom, J Toxicol, 2018, 1, 10.1155/2018/6940798 · doi:10.1155/2018/6940798
- Potet Id, 2019, Reviewing Evidence of the Clinical Effectiveness of Commercially Available Antivenoms in Sub-Saharan Africa Identifies the Need for a Multi-Centre, Multi-Antivenom Clinical Trial, PloS Negl Trop Dis, 13, 1, 10.1371/journal.pntd.0007551 · DOI
- Bulfone, 2018, Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite, J Trop Med, 2018, 1, 10.1155/2018/4320175 · DOI · Paper page
- Bittenbinder, 2019, Differential Destructive (non-Clotting) Fibrinogenolytic Activity in Afro-Asian Elapid Snake Venoms and the Links to Defensive Hooding Behavior, Toxicol Vitr, 60, 10.1016/j.tiv.2019.05.026 · DOI
- Boyer, 2015, Signs, Symptoms and Treatment of Envenomation, 32
Cited by
Smith, C. F., Modahl, C. M., Ceja Galindo, D., Larson, K. Y., Maroney, S. P., Bahrabadi, L., Brandehoff, N. P., Perry, B. W., McCabe, M. C., Petras, D., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100779 · Cited by 11
Metadata
- Authors
- Chowdhury, A., Lewin, M. R., Zdenek, C. N., Carter, R., & Fry, B. G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-10-07
- Volume
- 12
- ISSN
- 1664-3224
- Cited by
- 36
- References
- 1
- Funders
- Australian Research Council
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms. https://app.cochat.ai/papers/10.3389/fimmu.2021.752442
- The paper
- Chowdhury, A., Lewin, M. R., Zdenek, C. N., Carter, R., & Fry, B. G. (2021). The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.752442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.